ESR1 and breast cancer: In summary, we reported for the first time to our knowledge that a combination of LUT and I3C, at a low level without effect alone, synergistically suppresses cell proliferation only in ERα+ breast cancer (MCF7 and T47D), but not in TNBC cells.